16 completed, 4 not yet recruiting, 2 recruiting, 2 unknown. 11 Not applicable, 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 11 | Completed 6, Not yet recruiting 3, Recruiting 1, Terminated 1 |
| Phase 3 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Influenza B: new trials by email Literature Review of Influenza B trials Research Report on Influenza B
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Usability and Clinical Validation of the Flu A/B/COVID-19 + RSV Multiplex Rapid Test Flu A/B/COVID-19 + RSV Multiplex Rapid Test - SARS-CoV-2 Infection, Influenza A | Not applicable | Not yet recruiting | CorDx, Inc. | 1500 | 2026-11-01 | 2026-10-15 |
| Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp) Baloxavir, Placebo Control - Influenza A, Influenza B | Phase 3 | Recruiting | Unity Health Toronto | 264 | 2026-04-29 | 2026-08-18 |
| Clinical Validation of an At-Home Flu A/B and COVID-19 Rapid Test CorDx Tyfast Flu A/B & COVID-19 At-Home Multiplex Rapid Test - SARS-CoV-2 Infection, Influenza A | Not applicable | Not yet recruiting | CorDx, Inc. | 200 | 2026-02-12 | 2026-02-25 |
| Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Settings Aptitude Medical Systems Respiratory Panel Test - COVID -19, Influenza A | Not applicable | Not yet recruiting | Aptitude Medical Systems | 2000 | 2025-11-01 | 2025-10-16 |
| Phase III Clinical Trial of Quadrivalent Influenza Virus Split Vaccine QIV, QIV Control - Influenza, Human, Influenza, Human Prevention | Phase 3 | Not yet recruiting | Institute of Medical Biology, Chinese Academy of Medical Sciences | 4400 | 2025-02-08 | 2025-01-30 |
| Prospective Clinical Evaluation of COVID/Flu Detect™ Rapid Self-Test in Symptomatic Subjects for Non-Prescription Over-the-Counter (OTC) Use COVID/Flu Detect™ Rapid Self-Test - COVID-19, Influenza A | Completed | InBios International, Inc. | 899 | 2024-12-26 | 2025-05-22 | |
| Covid Flu A/B and RSV 4 in 1 Diagnostic Test Investigational Flu A/B Covid-19 and RSV Diagnostic Test - Influenza A, Influenza B | Completed | iHealth Labs inc | 1119 | 2024-11-15 | 2026-01-08 | |
| Evaluation of COVID-19 and Flu A/B 3 in 1 Combo Rapid Test Investigational Flu A/B And Covid-19 Diagnostic Test - COVID - 19, Influenza A | Completed | iHealth Labs inc | 588 | 2024-11-12 | 2026-01-08 | |
| A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients LIAISON NES FLU A/B, RSV & COVID-19 - Influenza a, Influenza B | Not applicable | Recruiting | DiaSorin Molecular LLC | 1000 | 2024-09-30 | 2024-11-04 |
| Predict + Protect Study: Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to ILI ILI Predictive Alerts, Reactive Content, and Proactive Content, ILI Predictive Alerts, Reactive Content, Proactive Content - Influenza, Influenza A | Not applicable | Completed | Evidation Health | 17043 | 2024-02-12 | 2024-09-19 |
| Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and Respiratory Viral Infections Influenza, Human, COVID-19 | Completed | Evidation Health | 18157 | 2024-01-21 | 2024-09-05 | |
| Clinical Performance Study for EDAN's COVID-19/Flu A/Flu B/RSV Test Kits on Subjects Suspected of Respiratory Infection COVID-19/Flu A/Flu B/RSV Test Kit - SARS-CoV2 Infection, Influenza A | Unknown | EDAN Instruments Inc. | 1000 | 2023-12-10 | 2024-01-11 | |
| SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings Aptitude Medical Systems Metrix COVID/Flu Test - SARS-CoV-2 Infection, Influenza A | Not applicable | Completed | Aptitude Medical Systems | 614 | 2023-11-20 | 2025-05-13 |
| Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel Panbio™ - COVID-19, Influenza A | Not applicable | Completed | Abbott Rapid Dx | 447 | 2023-11-14 | 2024-04-25 |
| Dose, Safety, and Pathogenicity of a New Influenza B Strain influenza B/Connecticut/1/21 virus part a dose arm 1, influenza B/Connecticut/1/21 virus part a dose arm 2, influenza B/Connecticut/1/21 virus part b dose 1 - Influenza B | Phase 2 | Unknown | Hvivo | 60 | 2023-10-03 | 2024-02-12 |
| Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Combo Test LumiraDx SARS-CoV-2 & Flu A/B - SARS-CoV-2, Influenza A | Completed | LumiraDx UK Limited | 1081 | 2023-05-04 | 2026-06-11 | |
| MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study MGC Health COVID-19 & Flu A+B Home Multi Test, MGC Health COVID-19 & Flu A+B Home Multi Test (2 to 13 y/o) - COVID-19, Influenza A | Not applicable | Completed | Medical Group Care, LLC | 34 | 2023-02-14 | 2024-05-02 |
| POC Performance Evaluation of LumiraDx SARS-CoV-2 Ag Ultra and SARS-CoV-2 & Flu A/B Tests. LumiraDx SARS-CoV-2 Ag Ultra, LumiraDx SARS-CoV-2 & Flu A/B - SARS-CoV-2, Influenza A | Completed | LumiraDx UK Limited | 716 | 2023-02-09 | 2026-06-12 | |
| Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml Vitamine D3 supplementation, Diet and sun exposure - Covid19, Influenza A | Not applicable | Terminated | Hospital Clinica Nova | 41 | 2020-08-05 | 2022-04-14 |
| Validation of the Ellume® Respirio Flu Test and the Ellume® eLab Flu Test for the Rapid Identification of Influenza A/B Respirio Flu Test, eLab Flu Test, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) - Influenza A, Influenza B | Not applicable | Completed | Ellume Pty Ltd | 1500 | 2016-07-01 | 2016-12-06 |
Showing 20 of 25. Sign in to see all of them.
COVID-19 (16) · Influenza, Human (7) · Coronavirus Infections (2) · Orthomyxoviridae Infections (2) · Adenoviridae Infections (1) · Communicable Diseases, Emerging (1) · Coxsackievirus Infections (1) · Infections (1) · Lung Diseases (1) · Paramyxoviridae Infections (1) · Respiratory Syncytial Virus Infections (1) · Respiratory Tract Infections (1)
RNA Virus Infections (20) · Virus Diseases (20) · Infections (19) · Respiratory Tract Diseases (19) · Respiratory Tract Infections (18) · Coronaviridae Infections (17) · Nidovirales Infections (17) · Pneumonia (16) · Pneumonia, Viral (16) · Coronavirus Infections (15) · Lung Diseases (15) · Orthomyxoviridae Infections (7) · Communicable Diseases (1) · DNA Virus Infections (1) · Disease Attributes (1)
Reverse Transcriptase Polymerase Chain Reaction (2) · Diet (1) · Immunoglobulins, Intravenous (1) · Standard of Care (1) · baloxavir (1)
Aptitude Medical Systems (2) · CorDx, Inc. (2) · Ellume Pty Ltd (2) · Evidation Health (2) · LumiraDx UK Limited (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · iHealth Labs inc (2) · Abbott Rapid Dx (1) · DiaSorin Molecular LLC (1) · EDAN Instruments Inc. (1) · Hospital Clinica Nova (1) · Hvivo (1) · IQuum, Inc. (1) · InBios International, Inc. (1) · Institute of Medical Biology, Chinese Academy of Medical Sciences (1)
United States (17) · Australia (3) · Puerto Rico (2) · United Kingdom (2) · Canada (1) · China (1) · Denmark (1) · Mexico (1) · Spain (1)
Andrew Pinto, MD (1) · Arnulfo Gonzalez-Cantu, MD (1) · Bernardine McKellar (1) · Brad W Killingsworth, M.A. (1) · Brian DuChateau, PhD (1) · Ernesto H.N. Ramirez, PhD (1) · Ernesto Ramirez, PhD (1) · Evan Jones (1) · James Pollard (1) · Janice Cattano, RN, MSN (1) · John Beigel, MD (1) · Luke Katahanas (1) · Noel Cranswick (1) · Norman P. Markowitz, MD (1)